Earlier quoted context omitted.
Actually, and this is very surprising, most multi-billion dollar biopharmaceutical companies do not have access to scientific literature. I have several friends that work in big Pharma (Merck, Pfizer, etc). The common scientist working there has zero access to scientific literature. They routinely read abstracts from Pubmed and then guess about the methods/results based on the abstract. Scary, but true. Management at…
If true - and you'll forgive me if I haven't yet picked my jaw up off the floor - this is the biggest argument for open publishing that I've seen yet. The situation is way worse than I thought.
I actually found out because I wanted to build a startup that used biomedical literature and biopharmaceutical companies. I basically axed the idea after talking to my friends.
To be fair, the decision to cut R&D in big Pharma is unrelated to the decision to remove literature subscriptions. It is just one of the strings of mismanagement episodes that pharma has performed.
If anyone is interested, this thread at SA is pure gold: http://forums.somethingawful.com/showthread.php?threadid=339...
In particular, these are some quality posts to show the absolute inane nature of big Pharma:
http://forums.somethingawful.com/showthread.php?threadid=339...
http://forums.somethingawful.com/showthread.php?threadid=339...
http://forums.somethingawful.com/showthread.php?threadid=339...
http://forums.somethingawful.com/showthread.php?threadid=339...
http://forums.somethingawful.com/showthread.php?threadid=339...